Arrears Clearance Framework
Kogi State -2020 -SARVCR-Report
[ download ]
Kogi State 2020 SARVCR Report
[ download ]
KOGI STATE CONTRACTUAL OBLIGATION as at December 31st 2020
[ download ]
Kogi State 2020 Arrears Clearance Framework
[ download ]
2019 Kogi ACF
[ download ]
Kogi State Arrears Clearance Framework 2019
[ download ]
Kogi State SARVCR Report
[ download ]
Kogi State SARVCR 2019
[ download ]
Contractual Obligation 2019
[ download ]
Kogi State Arrears Clearance Framework Document 2018
[ download ]
Contractor Arrears 2018
[ download ]
The biggest challenge was that Arguzo was not utilizing technology properly. Too much of the work was still being recorded manually, which meant that the numbers took a long time to note down and then to be analyzed. Live data was also not available and decisions can only be made after all the required data and been received. This was holding Arguzo back; they knew they could corner more of the market if they had the ability to be more mobile. The work addressed three critical issues for Pharm Ltd.:
The biggest challenge was that Arguzo was not utilizing technology properly. Too much of the work was still being recorded manually, which meant that the numbers took a long time to note down and then to be analyzed. Live data was also not available and decisions can only be made after all the required data and been received. This was holding Arguzo back; they knew they could corner more of the market if they had the ability to be more mobile. The work addressed three critical issues for Pharm Ltd.:
The biggest challenge was that Arguzo was not utilizing technology properly. Too much of the work was still being recorded manually, which meant that the numbers took a long time to note down and then to be analyzed. Live data was also not available and decisions can only be made after all the required data and been received. This was holding Arguzo back; they knew they could corner more of the market if they had the ability to be more mobile. The work addressed three critical issues for Pharm Ltd.: